<DOC>
	<DOCNO>NCT02427906</DOCNO>
	<brief_summary>The purpose study determine effect transjugular intrahepatic portosystemic shunt gut microbiota associate inflammatory factor cirrhotic patient .</brief_summary>
	<brief_title>Effect Transjugular Intrahepatic Portosystemic Shunt Gut Microbiota Cirrhotic Patients</brief_title>
	<detailed_description>Cirrhosis associate qualitative quantitative change gut microbiota potentiate disease progression complication hepatic encephalopathy ( HE ) infection . Dysbiosis alter gut microbiota , due decrease autochthonous commensal taxon , find stool colonic mucosa cirrhotic patient , turn link disease severity systemic inflammation . TIPS decompress hypertensive portal vein , intestinal congestion decrease . Hence summarize TIPS may effect gut microbiota associate inflammatory factor cirrhotic patient .</detailed_description>
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Liver Cirrhosis</mesh_term>
	<mesh_term>Brain Diseases</mesh_term>
	<mesh_term>Hepatic Encephalopathy</mesh_term>
	<criteria>Cirrhotic patient receive TIPS ; Treatmentnaive TIPS major operation involve liver surgical shunt , hepatic resection liver transplantation ) Uncontrolled infection sepsis ; Hepatobiliary pancreatic malignancy biliary obstruction ; Vital organ dysfunction ; Administration antibiotic ( TIPS 2 week TIPS ) ; Cachexia ; Pregnant breeding woman</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>cirrhosis</keyword>
	<keyword>gut microbiota</keyword>
	<keyword>transjugular portosystemic shunt</keyword>
	<keyword>hepatic encephalopathy</keyword>
</DOC>